The literature analysis reveals that the receptor for advanced glycation end products (RAGE) and its ligands link energy metabolism (often disrupted by mitochondrial dysfunction) to immune responses (shaped by local microbiota), impacting tumor development. Here, AGER is linked to neoplasm.